8 Yr child difficulty in opening eyelids and releasing pen from handgrip cilical feature dx dd investigations

Reading File
Finding Sources
Finding Sources
Searching PubMed

myotonic dystrophy children diagnosis

Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Searching Images

myotonic dystrophy facial features ptosis child

Finding Sources
Finding Sources
Reading File
Finding Sources
Loading Image
Loading Image
Searching the Web

myotonic dystrophy type 1 childhood juvenile differential diagnosis investigations management

I now have comprehensive information. Let me compile a detailed clinical answer.

8-Year-Old: Ptosis + Grip Myotonia — Clinical Analysis

Most Likely Diagnosis: Myotonic Dystrophy Type 1 (DM1 / Steinert's Disease)

The combination of difficulty opening eyelids (ptosis/levator myotonia) and inability to release pen grip (hand grip myotonia) in a child is the pathognomonic presentation of myotonic dystrophy. This is a trinucleotide repeat expansion disease with autosomal dominant inheritance.

Pathophysiology

  • Gene: DMPK gene on chromosome 19q13
  • Mutation: CTG trinucleotide repeat expansion (normal: 5–37 repeats; affected: 50 to several thousand)
  • Mechanism: "Toxic RNA gain-of-function" — expanded CUG RNA sequesters RNA-binding proteins (MBNL1), disrupting splicing of multiple genes including chloride channel (CLCN1), causing chloride channelopathy → myotonia
  • Inheritance: Autosomal dominant; anticipation occurs (earlier/more severe presentation with each generation due to increasing CTG repeats)

Clinical Features in Children (Juvenile/Childhood-Onset DM1)

Neuromuscular

FeatureDetail
Grip myotoniaCan't release pen/doorknob; improves with repetition ("warm-up phenomenon")
Eyelid myotonia / ptosisDifficulty opening eyes, especially in cold or after forceful closure
Facial diplegia"Hatchet face" — long, narrow face, temporal wasting, expressionless
Orbicularis oculi weaknessCannot bury eyelashes on forced closure
Distal > proximal weaknessFoot drop (gait abnormalities), wrist extensor/intrinsic hand weakness
Percussion myotoniaTapping thenar eminence → prolonged contraction
Tongue/jaw myotoniaDysarthria, nasal speech

Multisystem Involvement (Childhood DM1)

SystemManifestation
CardiacConduction defects, arrhythmias (bradycardia, heart block), sudden cardiac death
Cognitive/BehavioralIntellectual delay (90%), learning difficulties, ADHD, autism spectrum, social difficulties
OcularPosterior capsular cataracts (slit-lamp "Christmas tree" cataracts)
RespiratorySleep-disordered breathing, aspiration risk, diaphragmatic weakness
GIDysphagia, constipation, pseudo-obstruction, aspiration
EndocrineInsulin resistance, gonadal dysfunction (older onset)
CNSExcessive daytime somnolence, hypersomnia
SkeletalTalipes equinovarus in congenital form; joint contractures
In childhood-onset DM1, cognitive and fine motor difficulties dominate the clinical picture more than in adults — Robbins & Kumar Basic Pathology; Goldman-Cecil Medicine

Key Clinical Signs to Elicit

  1. Percussion myotonia — tap thenar eminence/tongue with tendon hammer → sustained contraction
  2. Warm-up phenomenon — myotonia decreases with repeated movements (distinguishes from paramyotonia)
  3. Handshake myotonia — patient cannot release handshake quickly
  4. Eye closure myotonia — after forced eye closure, eyes open slowly
  5. Hatchet face — temporalis/masseter wasting, elongated face
  6. Ptosis — bilateral, partial; differs from MG (no fatigability)
  7. Frontal balding (more pronounced in adults)
  8. Percussion dimple on tongue

Differential Diagnosis

ConditionKey Distinguishing Features
Myotonia Congenita (Thomsen/Becker)Myotonia only, no dystrophy, no systemic features; muscle hypertrophy ("Hercules" appearance); AD (Thomsen) or AR (Becker); CLCN1 mutations
Paramyotonia CongenitaMyotonia worsens with cold and exercise (no warm-up phenomenon); SCN4A mutation
Hyperkalemic Periodic Paralysis with myotoniaEpisodes of weakness triggered by K⁺, rest after exercise
Congenital Myopathy (nemaline, central core)No myotonia; early hypotonia; muscle biopsy diagnostic
Juvenile Myasthenia GravisFatigable ptosis and weakness; no myotonia; AChR/MuSK antibodies positive; Tensilon test positive
Congenital Myotonic DystrophyMore severe; neonatal hypotonia, respiratory failure, clubfoot; maternal inheritance common
Potassium-Aggravated MyotoniaWorsens with K⁺; no dystrophic features
Schwartz-Jampel SyndromeContinuous myotonia, dwarfism, bone dysplasia, blepharophimosis
Glycogen Storage Disease (Pompe)Myopathy + cardiomyopathy; elevated acid maltase
Key distinction: Myotonic Dystrophy = myotonia + dystrophy + multisystem involvement. Myotonia Congenita = myotonia only, no weakness/atrophy, no systemic features.

Investigations

First-Line

InvestigationExpected Finding
EMG (Electromyography)"Dive-bomber" myotonic discharges (waxing-waning frequency/amplitude); characteristic crackling sound
Serum CK (Creatine Kinase)Mildly elevated (2–5× normal); less elevated than DMD
Genetic testing (GOLD STANDARD)Southern blot or PCR for CTG repeat expansion in DMPK gene; >50 repeats confirms DM1

Second-Line / Systemic Evaluation

InvestigationPurpose
12-lead ECG + HolterCardiac conduction defects (PR prolongation, AV block, wide QRS)
EchocardiogramCardiomyopathy evaluation
Slit-lamp eye examinationPosterior capsular/subcapsular cataracts
Pulmonary function tests (spirometry)FVC; restrictive pattern from respiratory muscle weakness
Polysomnography (sleep study)Sleep-disordered breathing, central/obstructive apnea
Neuropsychological testingCognitive profile, learning disabilities
Fasting glucose / HbA1cInsulin resistance
Muscle biopsyRarely needed; shows type I fiber atrophy, internalized nuclei, ring fibers, sarcoplasmic masses
Brain MRIWhite matter changes (in cognitive DM1)
Family genetic screeningParents; affected mother carries risk of more severe congenital form

Management

Myotonia Treatment

  • Mexiletine (sodium channel blocker) — first-line for symptomatic myotonia
  • Alternatives: phenytoin, carbamazepine, acetazolamide
  • Avoid depolarizing agents (succinylcholine) — triggers myotonic crisis
  • Avoid cold exposure — worsens myotonia

Multidisciplinary Approach

DomainAction
CardiologyAnnual ECG; pacemaker/ICD if significant conduction disease
NeurologyRegular neuromuscular follow-up
RespiratoryCPAP/BiPAP if sleep apnea; physiotherapy
OphthalmologyAnnual slit-lamp; cataract surgery when indicated
PhysiotherapyMuscle strengthening, contracture prevention, splinting
EducationalSpecial educational needs support, speech therapy
Genetics counselingFor patient and family; discuss anticipation
Anaesthesia alertHigh anesthetic risk — prolonged neuromuscular blockade, respiratory depression, arrhythmias; regional preferred

Classic Teaching Points for Exams

  • "Warm-up phenomenon" = myotonia that improves with repeated activity → DM1 (contrast: paramyotonia worsens with activity)
  • "Dive-bomber" EMG = pathognomonic for myotonia
  • Anticipation: each generation gets more severe/earlier onset due to expanding CTG repeats
  • Maternal transmission → more likely to produce congenital DM1 (severe form)
  • Ptosis in DM1 is due to levator palpebrae myotonia + weakness, not fatigable (unlike MG)
  • DM1 is the most common adult-onset muscular dystrophy, but childhood/juvenile onset is well-recognized

Sources: Goldman-Cecil Medicine; Robbins & Kumar Basic Pathology; Bradley and Daroff's Neurology in Clinical Practice; Harrison's Principles of Internal Medicine 22E — Medical Library; Ho G et al. Arch Dis Child 2019 [PMID 29871899]; Myotonic Dystrophy Foundation Consensus Care Guidelines 2021.

Causes of recurrent proximal weakness dd chanalopathies,metabolic, nmj clically differentiate and investigations viva style

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
I now have all the key textbook content needed. Let me compile the comprehensive viva-style answer.

Recurrent Proximal Weakness — Viva-Style Deep Dive


Q1. What are the major categories causing recurrent (episodic) proximal weakness?

VIVA FRAMEWORK — "CHAMP-MN"
CategoryExamples
ChannelopathiesHypo/HyperKPP, Paramyotonia, Andersen-Tawil
Hormonal/MetabolicThyrotoxic PP, hypothyroid myopathy, Cushing's
Autoimmune NMJMyasthenia Gravis, Lambert-Eaton
Metabolic MyopathiesPompe, McArdle, carnitine deficiency
Periodic (secondary)Renal tubular acidosis, GI losses (secondary HypoKPP)
MitochondrialMELAS, CPEO — episodic weakness
Neuromuscular inflammatoryPolymyositis (periodic flares)

SECTION 1: CHANNELOPATHIES

Q2. Classify the skeletal muscle channelopathies

CHANNELOPATHIES
├── CALCIUM CHANNEL (CACNA1S)
│   └── Hypokalemic Periodic Paralysis Type 1 (HypoPP-1) — most common
├── SODIUM CHANNEL (SCN4A)
│   ├── Hyperkalemic Periodic Paralysis (HyperKPP)
│   ├── Hypokalemic Periodic Paralysis Type 2 (HypoPP-2)
│   ├── Paramyotonia Congenita (PMC)
│   └── Potassium-Aggravated Myotonia (PAM)
├── CHLORIDE CHANNEL (CLCN1)
│   ├── Myotonia Congenita — Thomsen (AD)
│   └── Myotonia Congenita — Becker (AR)
└── POTASSIUM CHANNEL (KCNJ2)
    └── Andersen-Tawil Syndrome (ATS)

Q3. Differentiate HypoPP vs HyperKPP clinically

FeatureHypoKPPHyperKPP
Gene/channelCACNA1S (Ca²⁺, type 1) / SCN4A (Na⁺, type 2)SCN4A (Na⁺ channel)
Serum K⁺ during attack< 3.0 mEq/L> 5.5 mEq/L (or normal)
Attack durationHours to days (longer)Minutes to hours (shorter)
Attack frequencyLess frequentMore frequent
TriggersHigh carbohydrate meal, insulin, rest after exercise, stress, hypothermiaRest after exercise, K⁺ ingestion, metabolic acidosis, hypothermia, fasting
Time of onsetOften on waking in morningOften during day
MyotoniaAbsentPresent (eyelids, tongue)
Bulbar/respiratorySparedSpared
Reflexes during attackReduced/absentReduced/absent
ECGFlat T waves, U waves, prolonged QTPeaked T waves, wide QRS
InheritanceADAD
Acute RxOral/IV KCl; avoid glucoseGlucose + insulin; inhaled salbutamol; avoid K⁺
ProphylaxisAcetazolamide, low Na⁺/carbohydrate dietAcetazolamide, frequent small meals, high carbohydrate
"In hypoPP, total body K⁺ is not depleted — it has shifted intracellularly; so K⁺ replacement must be cautious to avoid rebound hyperkalemia." — Rosen's Emergency Medicine

Q4. What is Paramyotonia Congenita (PMC) — how does it differ?

  • Mutation: SCN4A (Na⁺ channel gain-of-function)
  • Myotonia that WORSENS with activity and cold — opposite of warm-up phenomenon
  • Episodic paralysis can follow prolonged cold exposure
  • Key exam distinction: Myotonia congenita → warm-up ✅ | Paramyotonia → warm-up ❌ (worsens)
  • Exercise test: Short exercise → no drop in CMAP amplitude; Long exercise + cold → CMAP drops

Q5. Andersen-Tawil Syndrome (ATS) — "TRIAD"?

Triad:
  1. Periodic paralysis (hypo, hyper or normokalemic)
  2. Cardiac arrhythmias — prolonged QT, U waves, bidirectional VT → sudden cardiac death
  3. Dysmorphic features — low-set ears, hypertelorism, micrognathia, short stature, clinodactyly
KCNJ2 mutation (Kir2.1 potassium channel). Many patients need ICD implantation.

SECTION 2: METABOLIC MYOPATHIES

Q6. How do metabolic myopathies present with recurrent proximal weakness?

Core concept: Defect in energy supply to muscle → failure under metabolic stress
DiseaseDefectTriggerClinical Clue
McArdle (GSD V)Myophosphorylase (PYGM)Anaerobic exercise (short, intense)"Second wind" phenomenon; myoglobinuria; ischemic forearm test → no lactate rise
Pompe (GSD II)Acid maltase (α-glucosidase)Any exertion; respiratory failureProximal + respiratory weakness; macroglossia in infants; elevated CK; acid maltase assay diagnostic
Carnitine deficiencyCPT-I/II or carnitine transportProlonged exercise, fastingEpisodic weakness + rhabdomyolysis; myoglobinuria; lipid vacuoles on biopsy
Mitochondrial myopathyOXPHOS chain defectsExercise, metabolic stressElevated lactate/pyruvate; ragged-red fibers (Gomori trichrome); ophthalmoplegia (CPEO)
Thyrotoxic PPNa⁺/K⁺-ATPase overactivityHigh carbohydrate, exerciseHypoKPP + tremor, tachycardia, sweating; ↑ T₃/T₄, ↓ TSH; common in Asian males
"Second wind" in McArdle — Patient rests briefly when muscles tire (lactic block), then oxidative metabolism takes over → weakness resolves and exercise continues. This is pathognomonic.

Q7. Ischemic Forearm Exercise Test — what does it show?

ResultInterpretation
Normal: ↑ lactate + ↑ ammoniaNormal glycogenolysis
No rise in lactate, normal ammonia riseGSD (glycogen utilization defect) — McArdle
No rise in ammonia, normal lactateMyoadenylate deaminase deficiency
Both fail to riseImproper effort / inadequate ischemia (false positive)
Note: Non-ischemic version (without BP cuff) now preferred to avoid rhabdomyolysis.

SECTION 3: NMJ DISORDERS

Q8. Differentiate Myasthenia Gravis vs Lambert-Eaton Myasthenic Syndrome (LEMS)

FeatureMyasthenia Gravis (MG)Lambert-Eaton (LEMS)
PathophysiologyAutoantibodies against post-synaptic AChR (or MuSK) → ↓ ACh bindingAutoantibodies against pre-synaptic VGCC (P/Q-type) → ↓ ACh release
Site of defectPost-synapticPre-synaptic
Muscle distributionOcular + bulbar predominantly; limbs laterProximal limbs (legs > arms); ocular/bulbar mild
Characteristic weakness patternFatigable — worsens with sustained activityFacilitation — brief improvement with repeated activity, then fatigues
PtosisYes, fatigable; improves with ice testMild or absent
DiplopiaCommonRare
ReflexesNormalHyporeflexiaimproves after brief exercise (post-tetanic potentiation)
Autonomic featuresAbsentPresent: dry mouth, constipation, erectile dysfunction, blurred vision
Associated malignancyThymoma (10–15%)Small cell lung carcinoma (~50%)
AntibodiesAChR Ab (80–90%); MuSK Ab (5–10%); double-seroneg (5–10%)VGCC Ab (>85%)
RNS (3 Hz)Decremental response (>10–15% drop)Decremental at low freq; Incremental >100% at high freq (50 Hz) or post-exercise
SFEMGIncreased jitter ± blocking (most sensitive test)Increased jitter
TreatmentPyridostigmine, steroids, azathioprine, thymectomy, plasma exchange, IVIG, eculizumab, efgartigimodTreat underlying cancer; 3,4-DAP (amifampridine); IVIG, plasma exchange, immunosuppression

Q9. Describe the RNS (Repetitive Nerve Stimulation) pattern

                    MG                          LEMS
Low Hz (3Hz):   DECREMENTAL ↓↓↓↓↓          DECREMENTAL ↓↓↓↓↓
High Hz (50Hz): No increment               INCREMENTAL ↑↑↑↑ (>100%)
Post-exercise:  Repair of decrement        Marked increment (facilitation)
               (brief) then post-activation 
               exhaustion after 3-4 min
Mnemonic: "MG = Post-synaptic = Decremental; LEMS = Pre-synaptic = Facilitation"

SECTION 4: CLINICAL DIFFERENTIATION TABLE (MASTER)

FeatureHypoPPHyperKPPMGLEMSMetabolic Myopathy
Age of onsetTeensTeensAny (peak 20s F, 60s M)50s-60sChildhood/any
Pattern of weaknessProximal limbsProximal ± tongue/eyelidsOcular, bulbar, limbsProximal legsProximal limbs
FluctuationEpisodic attacksEpisodic attacksDiurnal (worse evening)Progressive ± brief facilitationExercise-triggered episodes
ReflexesAbsent during attackAbsent during attackNormalHyporeflexic (improve post-exercise)Normal (usually)
MyotoniaAbsentPresentAbsentAbsentAbsent
Autonomic featuresAbsentAbsentAbsentDry mouth, impotenceAbsent
Serum K⁺LowHighNormalNormalNormal
CKNormal/mildly ↑NormalNormalNormal↑↑ (markedly)
MyoglobinuriaAbsentAbsentAbsentAbsentPresent (McArdle, CPT II)
EMGNormal (inter-ictal)Myotonic dischargesNormal / ↑ jitter SFEMGFacilitation on RNSNormal / myopathic

SECTION 5: INVESTIGATION ALGORITHM

Q10. How do you investigate recurrent proximal weakness?

Step 1 — DURING attack (timing is critical)
  • Serum K⁺ (critical — determines channelopathy subtype)
  • ECG (hypoK → U waves; hyperK → peaked T)
  • Serum CK (markedly elevated → metabolic; mildly elevated → inflammatory/dystrophic)
  • Urine for myoglobin (rhabdomyolysis → McArdle, CPT II)
  • Thyroid function (TSH, T₃, T₄) — if first episode of HypoKPP
Step 2 — BETWEEN attacks (baseline)
TestTarget
Serum CK↑ → myopathy; normal → channelopathy, NMJ
EMG + NCSMyotonic discharges → channelopathy; decremental RNS → MG; incremental → LEMS
SFEMGMost sensitive for NMJ disease
AChR antibodiesMG (80–90% sensitivity)
MuSK antibodiesSeronegative MG
VGCC antibodiesLEMS (>85%)
CT chestThymoma (MG); SCLC (LEMS)
Short/long exercise test (NCS)Channelopathies — CMAP amplitude drop post-exercise
Ischemic forearm testGSD (no lactate rise)
Lactate/pyruvate ratioMitochondrial (>20:1 at rest)
Acid maltase (GAA) assayPompe disease (DBS/leukocytes)
Carnitine levelsCPT deficiency
Genetic panelCACNA1S, SCN4A, CLCN1, KCNJ2 for channelopathies
Muscle biopsyDefinitive for metabolic myopathies (enzyme histochemistry, EM)
Brain/spine MRIRule out CNS/cord cause of weakness

SECTION 6: HIGH-YIELD VIVA QUICK-FIRES

Q: What is the "second wind" sign and its significance? A: In McArdle disease (GSD-V), initial exercise causes myalgia/cramps due to blocked glycogenolysis. After brief rest, oxidative metabolism compensates and the patient can continue — pathognomonic of PYGM deficiency.
Q: Why does LEMS spare the eyes but MG primarily affects them? A: Ocular muscles have high-frequency NMJ firing and are especially dependent on ACh quantum content — post-synaptic receptor loss (MG) affects them maximally. LEMS affects ACh release across all muscle beds more uniformly, proximal limbs being most symptomatic.
Q: Thyrotoxic periodic paralysis — who gets it and why? A: Asian males predominantly. Excess thyroid hormone upregulates Na⁺/K⁺-ATPase activity → intracellular K⁺ shift → HypoKPP attacks. Treat: non-selective beta-blocker (propranolol) acutely + antithyroid therapy prevents recurrence.
Q: What is post-tetanic potentiation in LEMS? A: Rapid repetitive stimulation causes accumulation of Ca²⁺ at the presynaptic terminal → transiently overcomes the VGCC block → paradoxical increase in ACh release and strength. Clinically: patient's reflexes and power briefly improve after exercise.
Q: Andersen-Tawil — why is it unique among channelopathies? A: Only channelopathy with a cardiac + skeletal + dysmorphic triad. KCNJ2 mutation affects Kir2.1 channels expressed in both cardiac and skeletal muscle and in bone development. Risk of sudden cardiac death from bidirectional VT mandates cardiology follow-up ± ICD.
Q: Which anesthetic agents are dangerous in channelopathies? A:
  • Succinylcholine → triggers myotonia/myotonic crisis in all myotonias; prolonged muscle rigidity
  • Volatile agents (halothane, isoflurane) → can trigger hyperKPP attacks (membrane depolarization)
  • NMBDs: both depolarizing and non-depolarizing should be used cautiously in LEMS (profound sensitivity)

Sources: Rosen's Emergency Medicine; Bradley and Daroff's Neurology in Clinical Practice; Barash Clinical Anesthesia 9e; Morgan & Mikhail Clinical Anesthesiology 7e; Goldman-Cecil Medicine
This is a shared conversation. Sign in to Orris to start your own chat.